SEARCH RESULTS FOR:

Mining
Chile

Christian Cavagnaro

MANAGING DIRECTOR, TAKRAF CHILE
TAKRAF gives examples of how its material handling solutions benefit mines.
United States
Pharma & Life Sciences

John Pennett

PARTNER-IN-CHARGE OF THE NATIONAL TECHNOLOGY AND LIFE SCIENCES GROUP, EISNERAMPER
EisnerAmper speaks about the investment climate for pharma entrepreneurs.
United States
Pharma & Life Sciences

Swapan Bhattacharya

MANAGING DIRECTOR, TCG LIFESCIENCES
TCG Lifesciences explains its discovery engine aimed to build out a large portfolio of new chemical entities that can one day become marketed drugs
Mining
Peru
SPANISH

José Augusto Palma

NATIONAL SOCIETY OF MINING, PETROLEUM AND ENERGY (SNMPE); PRESIDENT OF THE ORGANIZING COMMITTEE, INTERNATIONAL GOLD, SILVER AND COPPER SYMPOSIUM
José Augusto Palma discusses the novelties of the 14th edition of the Gold, Silver and Copper Symposium and analyzes the competitiveness of Peru as a mining country.
Mining
Chile

Copper Production & Development in Chile

Chile Mining 2022 Pre-Release Edition
Investment and streamlined development is needed to capitalize on a generational opportunity.
Mining
Chile

Copper Exploration in Chile

Chile Mining 2022 Pre-Release Edition
Hunting for scale and a near-term path to production.
Mining
Chile

Iván Arriagada

CEO, ANTOFAGASTA PLC
Chile Mining 2022 Pre-Release Edition
Iván Arriagada provides an update on Antofagasta Minerals’ Chilean operations.
Mining
Chile

Don Lindsay

PRESIDENT & CEO, TECK RESOURCES LIMITED
Chile Mining 2022 Pre-Release Edition
Don Lindsay details the development of Teck’s QB2 project in Chile.
Mining
Chile

Joshua Olmsted

PRESIDENT AND COO – AMERICAS, FREEPORT-MCMORAN
Chile Mining 2022 Pre-Release Edition
Joshua Olmsted outlines Freeport McMoRan’s growth strategy in the Americas.
Mining
Chile

Aurora Davidson

PRESIDENT & CEO, AMERIGO RESOURCES
Chile Mining 2022 Pre-Release Edition
Aurora Davidson explains Amerigo Resources’ business model and evolution of the MVC operation.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL